SCHEMBL5031804

SCHEMBL5031804

CCOC(=O)C(O)(COCOC)Cc1ccc(OC)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
KMT2A Q03164 6/20 0.42
GLA P06280 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
GAA P10253 2/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 1/20 0.38
PTPRB P23467 1/20 0.38
MEN1 O00255 4/20 0.37
HTT P42858 2/20 0.37
MAPT P10636 1/20 0.37
CCR6 P51684 1/20 0.37
HKDC1 Q2TB90 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5031752 0.82 ALDH1A1 (0.48) ALDH1A1KMT2AGLAL3MBTL1GAA
SCHEMBL7128561 0.76 ALDH1A1 (0.50) ALDH1A1KMT2AGLAL3MBTL1GAA
SCHEMBL24733330 0.75 MMP8 (0.56) ALDH1A1KMT2AGLAL3MBTL1GAA
SCHEMBL3798352 0.75 KMT2A (0.50) ALDH1A1KMT2AGLAL3MBTL1GAA
SCHEMBL29277119 0.75 KMT2A (0.50) ALDH1A1KMT2AGLAL3MBTL1GAA
SCHEMBL3912206 0.74 ALDH1A1 (0.53) ALDH1A1KMT2AGLAL3MBTL1GAA
SCHEMBL11860695 0.71 KMT2A (0.47) ALDH1A1KMT2AGLAL3MBTL1GAA
SCHEMBL27728497 0.71 L3MBTL1 (0.54) ALDH1A1KMT2AGLAL3MBTL1GAA
SCHEMBL2241052 0.70 LDHA (0.49) ALDH1A1KDM4ELMNAHTTLDHA
SCHEMBL30513307 0.70 ALDH1A1 (0.60) ALDH1A1KMT2AL3MBTL1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371777-B2 Cyclic compound and PPAR agonist EISAI CO., LTD. (JP) 2008-05-13 US disclosed
US-7371777-B2 Cyclic compound and PPAR agonist EISAI CO., LTD. (JP) 2008-05-13 US disclosed
US-7371777-B2 Cyclic compound and PPAR agonist EISAI CO., LTD. (JP) 2008-05-13 US disclosed
US-20050014833-A1 Cyclic compound and ppar agonist EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-01-20 US disclosed
EP-1452521-A1 CYCLIC COMPOUND AND PPAR AGONIST Eisai Co., Ltd. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014833-A1 Cyclic compound and ppar agonist PPARA, PPARG, PPARD ALDH1A1 1662/4885KMT2A 1549/4885GLA 3760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.